Alexa Fluor® 594 anti-MART-1
Melan-A, also known as melanoma antigen recognized by T cells 1 (MART-1), antigen LB39-AA, and antigen SK29-AA, is an 18 kD transmembrane protein that is expressed in a large proportion of melanomas and melanoma cell lines.
PRODUCT DETAILS
Clone: M2-7C10
Antibody Type: Monoclonal
Reactivity: Human
Format: Alexa Fluor 594
Host: Mouse
Isotype: IgG2b, κ
Applications: IHC-P - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
More Images
Alexa Fluor® 594 anti-MART-1
Melan-A, also known as melanoma antigen recognized by T cells 1 (MART-1), antigen LB39-AA, and antigen SK29-AA, is an 18 kD transmembrane protein that is expressed in a large proportion of melanomas and melanoma cell lines.
PRODUCT DETAILS
Clone: M2-7C10
Antibody Type: Monoclonal
Reactivity: Human
Format: Alexa Fluor 594
Host: Mouse
Isotype: IgG2b, κ
Applications: IHC-P - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Melan-A, also known as melanoma antigen recognized by T cells 1 (MART-1), antigen LB39-AA, and antigen SK29-AA, is an 18 kD transmembrane protein that is expressed in a large proportion of melanomas and melanoma cell lines.
PRODUCT DETAILS
Clone: M2-7C10
Antibody Type: Monoclonal
Reactivity: Human
Format: Alexa Fluor 594
Host: Mouse
Isotype: IgG2b, κ
Applications: IHC-P - Quality tested
Regulatory Status: RUO
Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.
